Maryland 2022 Regular Session

Maryland Senate Bill SB984 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2
3	3	EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW.
4	4	[Brackets] indicate matter deleted from existing law.
5	5	sb0984
6	6
7	7	SENATE BILL 984
8	8	J1, J3 2lr3210
9	9	CF HB 1127
10	10	By: Senator Klausmeier
11	11	Introduced and read first time: February 18, 2022
12	12	Assigned to: Rules
13	13
14	14	A BILL ENTITLED
15	15
16	16	AN ACT concerning 1
17	17
18	18	Public Health – State Designated Exchange – Health Data Utility 2
19	19
20	20	FOR the purpose of requiring the State designated exchange to operate as a health data 3
21	21	utility for the State for certain purposes; requiring the Maryland Department of 4
22	22	Health, dispensers, and certain nursing homes and electronic health networks to 5
23	23	provide certain data to the State designated exchange; requiring dispensers to 6
24	24	submit certain prescription information to the State designated exchange; and 7
25	25	generally relating to the State designated exchange operating as a health data 8
26	26	utility. 9
27	27
28	28	BY adding to 10
29	29	Article – Health – General 11
30	30	Section 19–145 12
31	31	Annotated Code of Maryland 13
32	32	(2019 Replacement Volume and 2021 Supplement) 14
33	33
34	34	SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 15
35	35	That the Laws of Maryland read as follows: 16
36	36
37	37	Article – Health – General 17
38	38
39	39	19–145. 18
40	40
41	41	(A) (1) IN THIS SECTION THE F OLLOWING WORDS HAVE THE MEANINGS 19
42	42	INDICATED. 20
43	43
44	44	(2) “DISPENSER” MEANS A PERSON AUTHO RIZED BY LAW TO 21
45	45	DISPENSE, AS DEFINED IN § 12–101 OF THE HEALTH OCCUPATIONS ARTICLE, A 22
46	46	PRESCRIPTION DRUG TO A PATIENT OR THE PAT IENT’S AGENT IN THE STATE. 23
47	47	2 SENATE BILL 984
48	48
49	49
50	50	(3) “STATE DESIGNATED EXCH ANGE” HAS THE MEANING STAT ED IN § 1
51	51	4–302.3 OF THIS ARTICLE. 2
52	52
53	53	(B) THE STATE DESIGNATED EXCH ANGE SHALL OPERATE A S A HEALTH 3
54	54	DATA UTILITY FOR THE STATE. 4
55	55
56	56	(C) THE PURPOSES OF THE H EALTH DATA UTILITY I NCLUDE THE: 5
57	57
58	58	(1) THE COLLECTION , AGGREGATION , AND ANALYSIS OF CLIN ICAL 6
59	59	INFORMATION , PUBLIC HEALTH DATA , AND HEALTH ADMINISTR ATIVE AND 7
60	60	OPERATIONS DATA TO A SSIST HEALTH CARE AN D PUBLIC HEALTH LEADERS IN THE 8
61	61	EVALUATION OF PUBLIC HEALTH INTERVENTIONS AND HEALTH EQUITY ; 9
62	62
63	63	(2) THE COMMUNICATION OF DATA FROM PUBLIC HEA LTH OFFICIALS 10
64	64	AND HEALTH CARE PROV IDERS TO ADVANCE DIS EASE CONTROL AND HEA LTH 11
65	65	EQUITY; AND 12
66	66
67	67	(3) THE ENHANCEMENT AND ACCELERATION OF THE 13
68	68	INTEROPERABILITY OF HEALTH INFORMATION T HROUGHOUT THE STATE. 14
69	69
70	70	(D) THE FOLLOWING ENTITIE S SHALL PROVIDE DATA TO THE STATE 15
71	71	DESIGNATED EXCHANGE : 16
72	72
73	73	(1) THE DEPARTMENT ; 17
74	74
75	75	(2) NURSING HOMES REQUIRE D TO PROVIDE DATA UN DER § 4–302.3 18
76	76	OF THIS ARTICLE; 19
77	77
78	78	(3) ELECTRONIC HEALTH NET WORKS REQUIRED TO PR OVIDE DATA 20
79	79	UNDER § 4–302.3 OF THIS ARTICLE; AND 21
80	80
81	81	(4) DISPENSERS. 22
82	82
83	83	(E) (1) THE PURPOSE OF THIS S UBSECTION IS TO: 23
84	84
85	85	(I) AUTHORIZE INDIVIDUALS AND ORGANIZATIONS IN VOLVED 24
86	86	IN THE TREATMENT AND CARE COORDINATION OF PATI ENTS TO ACCESS , AS 25
87	87	LEGALLY AUTHORIZED , A PATIENT ’S MEDICATION HISTORY , INCLUDING 26
88	88	MEDICATIONS PRESCRIB ED FOR THE PATIENT ; AND 27
89	89
90	90	(II) ASSIST HEALTH CARE PR OVIDERS, CARE MANAGERS , AND 28
91	91	PUBLIC HEALTH OFFICI ALS TO UNDERSTAND AN D PROMOTE MAT TERS OF HEALTH 29
92	92	EQUITY AND TREATMENT EFFICACY. 30 SENATE BILL 984 3
93	93
94	94
95	95
96	96	(2) AFTER DISPENSING A PR ESCRIPTION DRUG , A DISPENSER SHALL 1
97	97	SUBMIT PRESCRIPTION INFORMATION TO THE STATE DESIGNATED EXCH ANGE. 2
98	98
99	99	(3) THE PRESCRIPTION INFO RMATION SHALL BE SUB MITTED: 3
100	100
101	101	(I) BY ELECTRONIC ME ANS; 4
102	102
103	103	(II) WITHOUT UNDULY INCREA SING THE WORKLOAD AN D 5
104	104	EXPENSE ON A DISPENS ER; 6
105	105
106	106	(III) IN A MANNER AS COMPAT IBLE AS POSSIBLE WIT H EXISTING 7
107	107	DATA SUBMISSION PRAC TICES, INCLUDING TECHNOLOGY SOFTWARE OF 8
108	108	DISPENSERS; AND 9
109	109
110	110	(IV) AS OTHERWISE REQUIRED BY REGULATIONS ADOPT ED BY 10
111	111	THE COMMISSION. 11
112	112
113	113	(4) THE STATE DESIGNATED EXCH ANGE MAY NOT IMPOSE ANY FEES 12
114	114	OR OTHER ASSESSMENTS ON DISPENSERS TO SUP PORT THE OPERATION O F THE 13
115	115	EXCHANGE. 14
116	116
117	117	(5) THE STATE DESIGNATED EXCH ANGE SHALL MAKE PRES CRIPTION 15
118	118	INFORMATION SUBMITTE D UNDER THIS SUBSECT ION AVAILABLE FOR PU RPOSES OF 16
119	119	TREATMENT AND CARE C OORDINATION OF A PAT IENT. 17
120	120
121	121	(F) THE STATE DESIGNATED EXCH ANGE SHALL PROVIDE D ATA, AS 18
122	122	ALLOWED BY LAW , TO INDIVIDUALS AND O RGANIZATIONS INVOLVE D IN THE 19
123	123	TREATME NT AND CARE COORDINA TION OF PATIENTS AND TO PUBLIC HEALTH 20
124	124	OFFICIALS TO SUPPORT PUBLIC HEALTH GOALS , THAT MAY INCLUDE : 21
125	125
126	126	(1) UNDERSTANDING AND PRO MOTING THE EQUITABLE 22
127	127	AVAILABILITY TO PATI ENTS OF PRESCRIPTION MEDICATIONS , INCLUDING FOR THE 23
128	128	TREATMENT OF INFE CTIOUS DISEASE; 24
129	129
130	130	(2) ASSISTING HEALTH CARE PROVIDERS, CARE MANAGERS , AND 25
131	131	PUBLIC HEALTH OFFICI ALS IN IDENTIFYING O PPORTUNITIES TO USE TREATMENTS 26
132	132	MORE EFFECTIVELY , INCLUDING FOR STEWAR DSHIP OF ANTIBIOTIC MEDICATIONS ; 27
133	133	AND 28
134	134
135	135	(3) ANY ADDITIONAL PATIEN T INTERVENTIONS AND ACTIVIT IES, 29
136	136	INCLUDING CASE INVES TIGATION. 30
137	137	4 SENATE BILL 984
138	138
139	139
140	140	(G) (1) THE COMMISSION, IN CONSULTATION WITH APPROPRIATE 1
141	141	STAKEHOLDERS , SHALL ADOPT REGULATI ONS TO CARRY OUT THI S SECTION. 2
142	142
143	143	(2) THE REGULATIONS SHALL INCLUDE: 3
144	144
145	145	(I) THE SPECIFIC DATA REQ UIRED TO BE PROVIDED UNDER 4
146	146	SUBSECTION (D) OF THIS SECTION; 5
147	147
148	148	(II) THE SPECIFIC PRESCRIP TION INFORMATION REQ UIRED TO 6
149	149	BE SUBMITTED UNDER S UBSECTION (E) OF THIS SECTION; 7
150	150
151	151	(III) THE TIME FRAME FOR SU BMITTING PRESCRIPTIO N 8
152	152	INFORMATION UNDER SU BSECTION (E) OF THIS SECTION; 9
153	153
154	154	(IV) THE ELECTRONIC MEANS AND MANNER BY WHICH 10
155	155	PRESCRIPTION INFORMA TION IS TO BE SUBMIT TED UNDER SUBSECTION (E) OF THIS 11
156	156	SECTION; AND 12
157	157
158	158	(V) PRESCRIPTION INFORMAT ION SUBMISSION 13
159	159	REQUIREMENTS THAT AL IGN WITH THE DATA SU BMISSION REQUIREMENT S ON 14
160	160	DISPENSERS OF MONITO RED PRESCRIPTION DRU GS UNDER TITLE 21, SUBTITLE 2A 15
161	161	OF THIS ARTICLE. 16
162	162
163	163	SECTION 2. AND BE IT FURTHER ENACTED, That on or before January 1, 2024, 17
164	164	the Maryland Department of Health, the Maryland Health Care Commission, and the State 18
165	165	designated exchange shall submit a report to the General Assembly, in accordance with § 19
166	166	2–1257 of the State Government Article, that identifies ongoing revenue sources to fund 20
167	167	the activities required under § 19–145 of the Health – General Article, as enacted by Section 21
168	168	1 of this Act. 22
169	169
170	170	SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 23
171	171	October 1, 2022. 24
172	172